Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: Analysis of National Health Insurance Fund Database

Condition:   Chronic Myeloid Leukaemia Interventions:   Drug: Bosutinib;   Drug: Imatinib;   Drug: Nilotinib;   Drug: Dasatinib;   Drug: Ponatinib Sponsor:   Pfizer Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials